Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014

We report 20 cases of extensively drug-resistant tuberculosis managed in France. Treatment was individualized and included bedaquiline and linezolid for most patients and surgery in 8 patients. At last follow-up (22 months), 19 patients had achieved conversion from positive to negative on culture te...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Emerging infectious diseases Ročník 22; číslo 3; s. 518 - 521
Hlavní autori:	Henry, Benoît, Revest, Matthieu, Dournon, Nathalie, Epelboin, Loïc, Mellon, Guillaume, Bellaud, Guillaume, Mordant, Pierre, Le Dû, Damien, Véziris, Nicolas, Bernard, Christine, Morel, Sébastien, Jauréguiberry, Stéphane, Michelet, Christian, Bricaire, François, Tattevin, Pierre, Caumes, Éric
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States U.S. National Center for Infectious Diseases 01.03.2016 Centers for Disease Control and Prevention
Predmet:	Adult Antitubercular agents Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Combined Modality Therapy Dispatch Drug therapy extensively drug-resistant tuberculosis Extensively Drug-Resistant Tuberculosis - epidemiology Extensively Drug-Resistant Tuberculosis - history Extensively Drug-Resistant Tuberculosis - therapy Female Follow-Up Studies France - epidemiology History, 21st Century Human health and pathology Humans Life Sciences Male MDR TB Microbial drug resistance multidrug-resistant tuberculosis Mycobacterium tuberculosis - drug effects Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014 Treatment Outcome Tuberculosis XDR TB France bacteria XDR TB tuberculosis multidrug-resistant tuberculosis bedaquiline TB thoracic surgery antimicrobial resistance extensively drug-resistant tuberculosis tuberculosis and other mycobacteria MDR TB France outcome
ISSN:	1080-6040, 1080-6059, 1080-6059
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!